Document is current
Any future updates will be listed below
-
Authors
Vega-Letter, Ana Maria
García-Guerrero, Cynthia
Yantén-Fuentes, Liliana
Pradenas, Carolina
Herrera-Luna, Yeimi
Lara-Barba, Eliana
Bustamante-Barrientos, Felipe A.
Rojas, Masyelly
Araya, María Jesús
Jeraldo, Nicole
Aros, Constanza
Troncoso, Francisca
Poblete, Daniela
Court, Angela
Ortloff, Alexander
Barraza, Jose
Velarde, Francesca
Farkas, Carlos
Carril, Claudio
Luque-Campos, Noymar
Almarza, Gonzalo
Barahona, Maximiliano
Matas, Jose
Cereceda, Lucas
Lorca, Rocío
Toledo, Jorge
Oyarce, Karina
Vernal, Rolando
Caicedo, Andrés
del Campo, Andrea
Hidalgo, Yessia
Elizondo-Vega, Roberto
Djouad, Farida
Khoury, Maroun
Figueroa, Fernando E.
Luz-Crawford, Patricia https://orcid.org/0000-0003-0067-7743
-
Funding
Funding for this research was provided by:
Agencia Nacional de Investigación y Desarrollo (#FB210024)
- License Information
-
More Information
Article History
Received: 10 June 2024
Accepted: 5 December 2024
First Online: 7 January 2025
Declarations
:
: All authors give their consent for publication.
: Dr. Maroun Khoury is the chief scientific officer of Cells for Cells, EVast Bio (both are Spin-off from the Universidad de los Andes, Chile), and REGENERO a Chilean consortium for regenerative medicine. He reports receiving grants from ANID (National agency for research and development) and stipend from Cells for Cells under a research contract with the Universidad de los Andes, Chile. In addition, Dr. Khoury is the inventor of patents related to mesenchymal stem cells including a patent WO2014135924A1 pending, a patent WO2017064670A2 pending, a patent WO2017064672A1 pending, and a patent WO/2019/051623 pending. Andrés Caicedo is the scientific founder and advisor of Dragon Biomed, an entrepreneurial initiative at the Universidad San Francisco de Quito (USFQ). He also serves as a scientific advisor in the Research and Development department of Luvigix. In these roles, he provides scientific guidance and expertise but does not participate in the decision-making processes or operational activities of either company.
